RelA and mitogen-activated protein kinase kinase kinases potently enhance lentiviral vector production.


Journal

Biochemistry and biophysics reports
ISSN: 2405-5808
Titre abrégé: Biochem Biophys Rep
Pays: Netherlands
ID NLM: 101660999

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 23 10 2023
revised: 29 12 2023
accepted: 02 01 2024
medline: 8 2 2024
pubmed: 8 2 2024
entrez: 8 2 2024
Statut: epublish

Résumé

The growing demands for gene therapy have encouraged development of safe and efficient lentiviral vector (LV) preparation. While much progress has been made in this field, it remains to be explored how to boost its production from producer cells. This paper reports that transient co-expression of RelA or several mitogen-activated protein kinase kinase kinases (MAP3Ks) with packaging constructs can potently enhance LV production in HEK293T producer cells. Adding in transfection a small amount of effector plasmid is sufficient to achieve 3- to 4-fold enhancement, which can further be augmented by co-expression of IκB kinase 2 or HIV Tat. It is also shown that expression of RelA or MAP3K1 can increase LV production in HEK293T/17SF cells grown in suspension. These results indicate that stimulation of intracellular signaling pathways in producer cells represents a powerful means for enhancing LV production.

Identifiants

pubmed: 38328371
doi: 10.1016/j.bbrep.2024.101637
pii: S2405-5808(24)00001-3
pmc: PMC10847020
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101637

Informations de copyright

© 2024 The Author.

Déclaration de conflit d'intérêts

The author has no known competing financial interests or personal relationships that might affect the research reported in this paper.

Auteurs

Shoji Yamaoka (S)

Department of Molecular Virology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, 113-8510, Japan.

Classifications MeSH